Filing Details
- Accession Number:
- 0001493152-24-033271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-20 16:17:55
- Reporting Period:
- 2024-08-16
- Accepted Time:
- 2024-08-20 16:17:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1717115 | Tempus Ai, Inc. | 600 West Chicago Avenue Suite 510 Chicago, IL 60654 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-16 | 4,609,400 | $1.50 | 4,609,400 | No | 4 | X | Direct | |
| Common Stock | Acquisiton | 2024-08-16 | 4,609,400 | $2.50 | 9,218,800 | No | 4 | X | Direct | |
| Common Stock | Acquisiton | 2024-08-16 | 3,500,000 | $5.07 | 12,718,800 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Disposition | 2024-08-16 | 4,609,400 | $0.00 | 4,609,400 | $1.50 |
| Common Stock | Warrant (Right to Buy) | Disposition | 2024-08-16 | 4,609,400 | $0.00 | 4,609,400 | $2.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-11-28 | 2024-12-31 | No | 4 | X | Direct |
| 0 | 2023-11-28 | 2025-12-31 | No | 4 | X | Direct |
Footnotes
- The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person.
Billionaire Hedge Funds
